Docetaxel and irinotecan (CPT-11) in the treatment of malignant pleural mesothelioma--a feasibility study. [electronic resource]
Producer: 20001031Description: 257-61 p. digitalISSN:- 0959-4973
- Aged
- Antineoplastic Agents, Phytogenic -- administration & dosage
- Antineoplastic Combined Chemotherapy Protocols -- adverse effects
- Camptothecin -- administration & dosage
- Docetaxel
- Feasibility Studies
- Female
- Humans
- Irinotecan
- Male
- Mesothelioma -- drug therapy
- Middle Aged
- Neoplasm Staging
- Neutropenia -- chemically induced
- Paclitaxel -- administration & dosage
- Pleural Neoplasms -- drug therapy
- Survival Rate
- Taxoids
- Treatment Outcome
No physical items for this record
Publication Type: Clinical Trial; Controlled Clinical Trial; Journal Article
There are no comments on this title.
Log in to your account to post a comment.